Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine;Aumento de las hospitalizaciones pediátricas por empiema en Australia tras la introducción de la vacuna conjugada antineumocócica heptavalente

Bulletin of the World Health Organization

Volumn 91, Issue 3, 2013, Pages 167-173

  Strachan, Roxanne E ^a   Snelling, Thomas L ^a   Jaffé, Adam ^b  

^a SYDNEY CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

DISEASE INCIDENCE; INFECTIOUS DISEASE; PNEUMONIA; VACCINATION; VACCINE;

ACTIVE IMMUNIZATION; ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BACTERIAL PNEUMONIA; CHILD; CHILD HOSPITALIZATION; EMPYEMA; HOSPITAL ADMISSION; HUMAN; ICD-10; INFECTIOUS PNEUMONIA; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; SCHOOL CHILD; VIRUS PNEUMONIA;

ADOLESCENT; AGE DISTRIBUTION; AUSTRALIA; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASES, EMERGING; EMPYEMA; HOSPITALIZATION; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; PNEUMOCOCCAL VACCINES; PNEUMONIA; VACCINES, CONJUGATE; YOUNG ADULT;

AUSTRALIA;

BACTERIA (MICROORGANISMS);

EID: 84874633088     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.109231     Document Type: Article

References (31)

1. Burgner D, Richmond P. The burden of pneumonia in children: an Australian perspective. Paediatr Respir Rev 2005;6:94-100. PMID:15911454
2. Strachan R, Jaffé A; Australian Research Network in Empyema. Assessment of the burden of paediatric empyema in Australia. J Paediatr Child Health 2009;45:431-6. doi:10.1111/j.1440-1754.2009.01533.x PMID:19722296
3. Strachan RE, Cornelius A, Gilbert GL, Gulliver T, Martin A, McDonald T etal.; Australian Research Network in Empyema. Bacterial causes of empyema in children, Australia, 2007-2009. Emerg Infect Dis 2011;17:1839-45. doi:10.3201/eid1710.101825 PMID:22000353
4. Whitney CG, Farley MM, Hadler JL, Harrison LH, Bennett NM, Lynfield R etal.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003;348:1737-46. doi:10.1056/NEJMoa022823 PMID:12724479
5. Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR Morb Mortal Wkly Rep 2008;57:144-8. PMID:18272956
6. Chapman KE, Wilson D, Gorton R. Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England. Epidemiol Infect 2012;5:1-9. doi:10.1017/S0950268812000763 PMID:22564258
7. Johnson DR, D'Onise K, Holland RA, Raupach JC, Koehler AP. Pneumococcal disease in South Australia: vaccine success but no time for complacency. Vaccine 2012;30:2206-11. doi:10.1016/j.vaccine.2011.12.119 PMID:22273663
8. Kellner JD, Vanderkooi OG, MacDonald J, Church DL, Tyrrell GJ, Scheifele DW. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 2009;49:205-12. doi:10.1086/599827 PMID:19508165
9. Lacapa R, Bliss SJ, Larzelere-Hinton F, Eagle KJ, McGinty DJ, Parkinson AJ et al. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Clin Infect Dis 2008;47:476-84. doi:10.1086/590001 PMID:18627249
10. Calbo E, Díaz A, Cañadell E, Fábrega J, Uriz S, Xercavins M etal.; Spanish Pneumococcal Infection Study Network. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect 2006;12:867-72. doi:10.1111/j.1469-0691.2006.1502_1.x PMID:16882291
11. Hendrickson DJ, Blumberg DA, Joad JP, Jhawar S, McDonald RJ. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2008;27:1030-2. doi:10.1097/INF.0b013e31817e5188 PMID:18845981
12. Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006;25:250-4. doi:10.1097/01.inf.0000202137.37642.ab PMID:16511389
13. Bekri H, Cohen R, Varon E, Madhi F, Gire R, Guillot F etal. Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France. Arch Pediatr 2007;14:239-43. PMID:17276044
14. Byington CL, Spencer LY, Johnson TA, Pavia AT, Allen D, Mason EO etal. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: Risk factors and microbiological associations. Clin Infect Dis 2002;34:434-40. PMID:11797168
15. Calbo E, Garau J. Invasive pneumococcal disease in children: changing serotypes and clinical expression of disease. Clin Infect Dis 2005;41:1821-2. PMID:16288412
16. Obando I, Arroyo LA, Sanchez-Tatay D, Moreno D, Hausdorff WP, Brueggemann AB. Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples. Pediatr Infect Dis J 2006;25:962-3. PMID:17006306
17. Obando I, Arroyo LA, Sanchez-Tatay D, Tarrago D, Moreno D, Hausdorff WP et al. Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine. Clin Microbiol Infect 2007;13:347-8. PMID:17391398
18. Roxburgh CS, Youngson GG, Townend JA, Turner SW. Trends in pneumonia and empyema in Scottish children in the past 25 years. Arch Dis Child 2008;93:316-8. doi:10.1136/adc.2007.126540 PMID:18006562
19. Koshy E, Murray J, Bottle A, Sharland M, Saxena S. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax 2010;65:770-4. doi:10.1136/thx.2010.137802 PMID:20805169
20. Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M etal.; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 2011;66(Suppl 2):ii1-23. doi:10.1136/thoraxjnl-2011-200598 PMID:21903691
21. Madhi SA, Klugman KP; Vaccine Trialist Group. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004;10:811-3. doi:10.1038/nm1077 PMID:15247911
22. Australian Bureau of Statistics [Internet]. Aboriginal and Torres Strait Islander population estimates, 2011-preliminary. Camberra: ABS; 2012. Available from: http://www.abs.gov.au/ausstats/abs@.nsf/Latestproducts/3101.0Feature%20Article1Mar%202012?opendocument&tabname=Summary&prodno=3101.0&issue=Mar%202012&num=&view= [accessed 10 December 2012].
23. Strachan RE, Cornelius A, Gilbert GL, Gulliver T, Martin A, McDonald T etal. Pleural fluid nucleic acid testing enhances pneumococcal surveillance in children. Respirology 2012;17:114-9. doi:10.1111/j.1440-1843.2011.02035.x PMID:21848709
24. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005;5:83-93. PMID:15680778
25. Luján M, Gallego M, Belmonte Y, Fontanals D, Vallès J, Lisboa T et al. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J 2010;36:1073-9. doi:10.1183/09031936.00176309 PMID:20150202
26. Eastham KM, Freeman R, Kearns AM, Eltringham G, Clark J, Leeming J etal. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax 2004;59:522-5. doi:10.1136/thx.2003.016105 PMID:15170039
27. Playfor SD, Smyth AR, Stewart RJ. Increase in incidence of childhood empyema. Thorax 1997;52:932. PMID:9404386
28. Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA etal. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007;297:1784-92. doi:10.1001/jama.297.16.1784 PMID:17456820
29. Sonnappa S, Cohen G, Owens CM, van Doorn C, Cairns J, Stanojevic S etal. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006;174:221-7. doi:10.1164/rccm.200601-027OC PMID:16675783
30. St Peter SD, Tsao K, Harrison C, Jackson MA, Spilde TL, Keckler SJ etal. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 2009;44:106-11.-discussion 111. doi:10.1016/j.jpedsurg.2008.10.018 PMID:19159726
31. Lorgelly PK, Atkinson M, Lakhanpaul M, Smyth AR, Vyas H, Weston V et al. Oral versus i.v. antibiotics for community-acquired pneumonia in children: a cost-minimisation analysis. Eur Respir J 2010;35:858-64. doi:10.1183/09031936.00087209 PMID:19717479